SecBot SecBot
3 ·Filed Nov 6, 2026

TXG

10x Genomics, Inc.
NEUTRAL
Impact 1/10
Horizonimmediate Processed10d 6h ago SEC0001610717-26-000448
Form 3: initial insider ownership statement
Actionable Insight • Neutral

This is a standard initial ownership filing for a new insider. No trading signal; monitor future Form 4 filings for any material transactions by Gilliam.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$65.05
T+0 close · Nov 6, 2026 · via day close
Latest settled
−15.46%
T+5 · $54.99
Vs SPY
−13.77%
α at T+5
Next horizon
T+20
in 21d
  1. T+0 · Nov 9 $65.05entry
  2. T+1 · 7d ago −3.31%α −2.94% · $62.90
  3. T+5 · 16h ago −15.46%α −13.77% · $54.99
  4. T+20 · in 21d Pending
  5. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Joseph E. Gilliam filed a Form 3 initial statement of beneficial ownership, reporting 31 shares of Class A Common Stock. The filing also includes a power of attorney authorizing Randy Wu and James Bryant to execute Section 16 filings on his behalf. This is a routine insider onboarding filing with no material financial impact.

Key Facts

  • Joseph E. Gilliam filed a Form 3 initial statement of beneficial ownership on 2026-11-06.
  • Gilliam reports beneficial ownership of 31 shares of Class A Common Stock.
  • A power of attorney (Exhibit 24.1) was filed, appointing Randy Wu and James Bryant as attorneys-in-fact for Section 16 filings.
  • The filing is dated as of the event date 2026-10-28.

Financial Impact

Insider holds 31 shares, negligible relative to $8.8B market cap.

Market Snapshot

Exchange
Nasdaq
Sector
Laboratory Analytical Instruments
Analyst Consensus
48% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001610717-26-000448
Document: 0001610717-26-000448-index-headers.html0001610717-26-000448
Document: 0001610717-26-000448-index.html0001610717-26-000448
Document: 0001610717-26-000448.txt0001610717-26-000448

Track record

28 reports on TXG

Performance horizon

1 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +8.89% at T+60 after the Aug 19, 2026 report. 2 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $55.40 Now $54.99 −0.74% settles Feb 12
  2. Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $54.99 −15.47% settles Feb 5
  3. Nov 6, 202610d ago 3 Neutral 1/10 Viewing Entry $65.05 Now $54.99 −15.47% settles Feb 5
  4. Nov 5, 202611d ago 8-K Bullish 6/10 No price data
  5. Nov 5, 202611d ago Press Release Mixed 5/10 Entry $59.28 Now $54.99 −7.24% settles Feb 4
  6. Nov 2, 202614d ago 8-K Neutral 2/10 Entry $65.29 Now $54.99 −15.78% settles Feb 1
  7. Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $71.55 Now $54.99 −23.14% settles Jan 21
  8. Oct 7, 20265w ago SC 13G/A Neutral 2/10 Entry $77.28 Now $54.99 −28.84% settles Jan 5
  9. Sep 24, 20267w ago Insider Cluster Neutral 3/10 Entry $85.71 Now $54.99 −35.84% settles Dec 21
  10. Sep 22, 20267w ago 144 Neutral 2/10 Entry $75.62 Now $54.99 −27.28% settles Dec 17
Showing 10 of 28

US Market Status

Market Closed · Opens Wed (10h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026